These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 12798178)

  • 1. Simultaneous enantiospecific separation and quantitation of mephenytoin and its metabolites nirvanol and 4'-hydroxymephenytoin in human plasma by liquid chromatography.
    Jansson B; Simonsson US; Ashton M
    J Chromatogr B Analyt Technol Biomed Life Sci; 2003 Jul; 791(1-2):179-91. PubMed ID: 12798178
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enantiospecific separation and quantitation of mephenytoin and its metabolites nirvanol and 4'-hydroxymephenytoin in human plasma and urine by liquid chromatography/tandem mass spectrometry.
    Jansson B; Elsherbiny D; Simonsson US
    Rapid Commun Mass Spectrom; 2006; 20(3):463-72. PubMed ID: 16395737
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of urinary mephenytoin metrics to phenotype for CYP2C19 and CYP2B6 activity.
    Klaassen T; Jetter A; Tomalik-Scharte D; Kasel D; Kirchheiner J; Jaehde U; Fuhr U
    Eur J Clin Pharmacol; 2008 Apr; 64(4):387-98. PubMed ID: 18071681
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantification of mephenytoin and its metabolites 4'-hydroxymephenytoin and nirvanol in human urine using a simple sample processing method.
    Klaassen T; Kasel D; Harlfinger S; Fuhr U
    Rapid Commun Mass Spectrom; 2004; 18(15):1675-80. PubMed ID: 15282764
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CYP2C19-mediated (S)-mephenytoin 4'-hydroxylation assayed by high-performance liquid chromatography with radiometric detection.
    Crespi CL; Chang TK; Waxman DJ
    Methods Mol Biol; 2006; 320():115-9. PubMed ID: 16719381
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-performance liquid chromatographic determination of urinary 4'-hydroxymephenytoin, a metabolic marker for the hepatic enzyme CYP2C19, in humans.
    Xie HG; Huang SL; Zhou HH
    J Chromatogr B Biomed Appl; 1995 Jun; 668(1):125-31. PubMed ID: 7550968
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stereoselective determination of the CYP2C19 probe drug mephenytoin in human urine by gas chromatography-mass spectrometry.
    Nolin TD; Frye RF
    J Chromatogr B Analyt Technol Biomed Life Sci; 2003 Jan; 783(1):265-71. PubMed ID: 12450547
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Catalytic role of cytochrome P4502B6 in the N-demethylation of S-mephenytoin.
    Heyn H; White RB; Stevens JC
    Drug Metab Dispos; 1996 Sep; 24(9):948-54. PubMed ID: 8886603
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phenotyping of CYP2C19 with enantiospecific HPLC-quantification of R- and S-mephenytoin and comparison with the intron4/exon5 G-->A-splice site mutation.
    Brockmöller J; Rost KL; Gross D; Schenkel A; Roots I
    Pharmacogenetics; 1995 Apr; 5(2):80-8. PubMed ID: 7663532
    [TBL] [Abstract][Full Text] [Related]  

  • 10. No correlation between side-chain of propranolol oxidation and S-mephenytoin 4'-hydroxylase activity.
    Xie HG; Xu ZH; Huang SL; Liu JH; Wu JX; Jiang CH; Zhou HH
    Zhongguo Yao Li Xue Bao; 1997 May; 18(3):216-8. PubMed ID: 10072936
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CYP2B6, CYP3A4, and CYP2C19 are responsible for the in vitro N-demethylation of meperidine in human liver microsomes.
    Ramírez J; Innocenti F; Schuetz EG; Flockhart DA; Relling MV; Santucci R; Ratain MJ
    Drug Metab Dispos; 2004 Sep; 32(9):930-6. PubMed ID: 15319333
    [TBL] [Abstract][Full Text] [Related]  

  • 12. (+)-N-3-Benzyl-nirvanol and (-)-N-3-benzyl-phenobarbital: new potent and selective in vitro inhibitors of CYP2C19.
    Suzuki H; Kneller MB; Haining RL; Trager WF; Rettie AE
    Drug Metab Dispos; 2002 Mar; 30(3):235-9. PubMed ID: 11854139
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determination of S/R ratio of mephenytoin in human urine by chiral HPLC and ultraviolet detection and its comparison with gas chromatography.
    Huang SL; Xie HG; Wang W; Xu ZH; Jiang CH; Zhou HH
    Zhongguo Yao Li Xue Bao; 1998 Nov; 19(6):548-50. PubMed ID: 10437143
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stereoselective metabolism of methadone N-demethylation by cytochrome P4502B6 and 2C19.
    Gerber JG; Rhodes RJ; Gal J
    Chirality; 2004 Jan; 16(1):36-44. PubMed ID: 14628297
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determination of fluoxetine and norfluoxetine in human plasma by high-performance liquid chromatography with ultraviolet detection in psychiatric patients.
    LLerena A; Dorado P; Berecz R; González A; Jesús Norberto M; de la Rubia A; Cáceres M
    J Chromatogr B Analyt Technol Biomed Life Sci; 2003 Jan; 783(1):25-31. PubMed ID: 12450521
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A model based assessment of the CYP2B6 and CYP2C19 inductive properties by artemisinin antimalarials: implications for combination regimens.
    Elsherbiny DA; Asimus SA; Karlsson MO; Ashton M; Simonsson US
    J Pharmacokinet Pharmacodyn; 2008 Apr; 35(2):203-17. PubMed ID: 18350255
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human N-demethylation of (S)-mephenytoin by cytochrome P450s 2C9 and 2B6.
    Ko JW; Desta Z; Flockhart DA
    Drug Metab Dispos; 1998 Aug; 26(8):775-8. PubMed ID: 9698292
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Artemisinin autoinduction is caused by involvement of cytochrome P450 2B6 but not 2C9.
    Simonsson US; Jansson B; Hai TN; Huong DX; Tybring G; Ashton M
    Clin Pharmacol Ther; 2003 Jul; 74(1):32-43. PubMed ID: 12844133
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sensitive determination of omeprazole and its two main metabolites in human plasma by column-switching high-performance liquid chromatography: application to pharmacokinetic study in relation to CYP2C19 genotypes.
    Shimizu M; Uno T; Niioka T; Yaui-Furukori N; Takahata T; Sugawara K; Tateishi T
    J Chromatogr B Analyt Technol Biomed Life Sci; 2006 Mar; 832(2):241-8. PubMed ID: 16497565
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective effect of liver disease on the activities of specific metabolizing enzymes: investigation of cytochromes P450 2C19 and 2D6.
    Adedoyin A; Arns PA; Richards WO; Wilkinson GR; Branch RA
    Clin Pharmacol Ther; 1998 Jul; 64(1):8-17. PubMed ID: 9695714
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.